Kevin Hykes
CIK 1467748 · PRES & CEO · last filed 2026-03-03
Kevin Hykes is a PRES & CEO who has filed 21 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing, for CVRX, was dated Mar 3, 2026. Across all open-market trades the lifetime net is +$261.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.43M
2
21
$261.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVRX | PRES & CEO | 284,237 | $5.03 | $1.43M | $213.6K | 8 | 2026-03-03 |
| HANSEN MEDICAL INC (HNSN) Delisted | Director | 701,101 | — | — | $47.5K | 12 | 2015-06-15 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | CVRX | Mixed | +151,237 | -$61.3K | EDGAR |
| 2025-05-12 | CVRX | Buy (P) | +5,000 | $24.2K | EDGAR |
| 2025-03-04 | CVRX | Grant (A) | +98,000 | $0 | EDGAR |
| 2024-08-05 | CVRX | Buy (P) | +30,000 | $250.8K | EDGAR |
| 2024-08-02 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-14 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2023-06-07 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2022-12-23 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2016-07-29 | — | Disp (D) | −70,110 | -$280.4K | |
| 2015-06-15 | HANSEN MEDICAL INC (HNSN) Delisted | Grant (A) | — | $0 | EDGAR |